Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Epicentre’s New Ribo-Zero™ Magnetic Gold and ScriptSeq™ Complete Gold Kits

Published: Monday, September 02, 2013
Last Updated: Sunday, September 01, 2013
Bookmark and Share
Cambio now supplies Epicentre’s new kits for yeast rRNA extraction.

Epicentre’s new Ribo-Zero™ Magnetic Gold Kit (yeast) enables the rapid, effective depletion of rRNA from intact or partially degraded yeast RNA samples.

Fast and easy to use, the Ribo-Zero™ Magnetic Gold technology uses a single-pass process which enables whole transcriptome RNA sequencing of mRNA and non-coding, non-ribosomal RNAs.

Ribo-Zero™ Magnetic Gold Kit (Yeast) depletes rRNA from S. cerevisiae, S. pombe and other yeast species.

The convenient magnetic bead format allows integration with both automated and manual processes, depending on user preferences and laboratory procedures.

Ribo-Zero™ Magnetic Gold is also available in an optimized format that includes ScriptSeq V2 RNA-Seq Library Preparation kit called ScriptSeq™ Complete Gold Kit (Yeast).

This innovative combination produces cluster-ready, rRNA-free whole transcriptome RNA-Seq libraries from yeast samples in just 7 hours.

The libraries are index-compatible (with additional ScriptSeq™ Index PCR Primers), and typically contain less than 3% rRNA reads.

With these kits, researchers can be confident of producing high-quality RNA-Seq libraries in the most time-efficient way. A low-input version of the ScriptSeq™ Complete Gold Yeast kit, for 100 ng - 1 µg of total RNA, will also be available soon.

Both of the new kits are supplied exclusively in the UK by Cambio, a leading supplier of quality Molecular Biology reagents and supplies.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Detection of HPV in First-Void Urine
Similar sensitivity of HPV test on first void urine sample compared to cervical smear.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
First Gene Therapy Successful Against Human Aging
American woman gets biologically younger after gene therapies.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!